Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

34.10 +0.18 (+0.53%)
Streaming Delayed Price Updated: 10:39 AM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
News headline image
Price To Earnings Ratio Insights For Teva Pharmaceutical ↗
  
Via Benzinga
News headline image
Teva, Texas Enter $225M Opioid Settlement Agreement ↗
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached a  
Via Benzinga
News headline image
Teva Reaches Agreement With Texas to Settle the State’s Opioid-Related Claims
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Weakened Tech Stocks ↗
There was a 0.5% rise in UK interest rates, twice what had been anticipated and moreover early, because of inflation risks. 
Via Talk Markets
News headline image
World Markets News for Wednesday ↗
Gold and the Euro are up as the greenback loses traction. 
Via Talk Markets
News headline image
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big... 
Via Benzinga
News headline image
World Markets News for Tuesday ↗
Exxon is splitting into 3 with its new restructuring move: upstream; chemicals; and low-carbon. 
Via Talk Markets
News headline image
Research Finds COVID Pandemic Worsened Health Equity Gap
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Drug Troubles ↗
The drug sector has both good news and bad. 
Via Talk Markets
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022 ↗
Upgrades 
Via Benzinga
News headline image
The Best REITs To Buy Right Now Will Pay 8.5% Yield ↗
Stocks had a great 2021, if a tad wild - the S&P 500 finished up nearly 27% for the year. But the performance of real estate investment trusts (REITs) last year flat-out blew stocks out of the water -... 
Via Talk Markets
News headline image
7 Stocks to Buy That Are Nowhere Near Being Overvalued ↗
These stocks to buy are above their lows and appear overvalued. They have more upside as growth drivers emerge lifting their prospects. 
Via InvestorPlace
News headline image
Chopped Stocks ↗
The day's theme is sell tech and buy banks. 
Via Talk Markets
News headline image
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance at 8 a.m. ET on February 9, 2022
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
More Serious Matters ↗
Wall Street fell on new worries about inflation and a drop in retail sales levels. 
Via Talk Markets
News headline image
Two Curses Of The Current Year ↗
The good news on inflation after this week's shocker is that December wholesale prices only rose 0.2%. 
Via Talk Markets
News headline image
Start Of The Week ↗
British property (real estate) stocks fell today. 
Via Talk Markets
News headline image
Post-Fed Thursday ↗
Companies earning in dollars but incorporated abroad and paying dividends in other currencies were big gainers today. 
Via Talk Markets
News headline image
Good Deed Turns Sour ↗
Kazakhstan, which supplies 40% of the uranium the world uses now, has entered a state of emergency. It is likely that uranium mining will be hit with strikes. 
Via Talk Markets
News headline image
Teva to Present at the 40th Annual J.P. Morgan Healthcare Conference
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Start Of 2022 ↗
Mohammed El Erien predicts that the Fed will be slamming on the brakes this year. 
Via Talk Markets
News headline image
Teva Suffers Loss In New York's Opioid Trial ↗
A jury in Suffolk County State Supreme Court found Teva Pharmaceutical Industries Ltd (NYSE: TEVA) contributed to New York's opioid epidemic. Next, the court ... 
Via Benzinga
News headline image
Teva Statement Following New York Jury Ruling in Opioids Trial
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Market Trend: Erratic And Unreliable ↗
Given the risks of covid variants and hefty price rises, the stock market should not be as buoyant as it is. 
Via Talk Markets
News headline image
Markets Inching Up ↗
As both China and the SEC are cracking down on Variable Interest Entities raising funds as if they were stocks, these are now in the dumps. 
Via Talk Markets
News headline image
Teva Pharmaceuticals To Market Cannabis Oils From Cannabit-Tikun Olam In Israel, Palestine, Ukraine ↗
Cannbit-Tikun Olam (TASE:TKUN) will produce various medical cannabis products for Teva Israel, a marketing arm of Teva Pharmaceuticals (NYSE: TEVA). What Happened The... 
Via Benzinga
News headline image
Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table ↗
This article was originally published on The Bluntness, and ... 
Via Benzinga
News headline image
Teva Announces Launch of First-to-Market Generic Version of Narcan® (Naloxone Hydrochloride Nasal Spray), in the U.S.
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Plague Year Reversal ↗
Just in time for Christmas, the market decided to go up today pretty much across the board. 
Via Talk Markets
News headline image
Dreaming Of A Red Christmas ↗
The stock market is reacting with lots of selling to the weekend's news. 
Via Talk Markets
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.